Case Analysis and Literature Review of a Case of Acarbose-induced Skin ADR by Clinical Pharmacists
- VernacularTitle:临床药师对1例阿卡波糖致皮肤不良反应的分析及文献回顾
- Author:
Leilei MEI
1
;
Feng REN
2
;
Weifang ZHANG
1
;
Jinjin WAN
1
;
Shanshan XIE
1
;
Jia LIANG
1
;
Jiangen AO
1
;
Chao ZHOU
3
Author Information
1. Dept. of Pharmacy，the Second Affiliated Hospital of Nanchang University，Nanchang 330006，China
2. Jiangxi Drug Inspection Center，Nanchang 330046，China
3. Dept. of Neurology，Jiangxi Provincial People’s Hospital，Nanchang 330006，China
- Publication Type:Journal Article
- Keywords:
Acarbose;
Skin r elated ADR;
Clinical characteristics;
Case analysis;
Literature review;
Clinical pharmacists
- From:
China Pharmacy
2021;32(20):2538-2542
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVE：To summarize and analyze t he clinical characteristics of acarbose-induced skin ADR ，and to provide reference for its therapy. METHODS ：Clinical pharmacists participated in the treatment of a patient with acarbose-induced skin ADR. The patient developed erythema multiforme several days after oral administration of Acarbose tablets （100 mg/d）. After consultation by dermatology and clinical pharmacy ，considering that the adverse reaction was related to acarbose ，clinical pharmacists suggested to stop the drug. Based on the above cases ，clinical pharmacists searched Wanfang database ，CNKI， PubMed，Embase and other databases to collect case reports of skin ADR caused by acarbose ，summarize its general situation （gender，age，usage and dosage ，etc.），latency，ADR（diagnosis and manifestation ），intervention and outcome ，etc. RESULTS ： The doctor adopted the pharmacist s’advice，stopped the use of acarbose ，and gave symptomatic treatment as Methylprednisolone sodium succinate for injection 40 mg（intravenous injection ，qd）+Medloratadine tablets 8.8 mg（oral administration ，qd）+Calamine lotion（for external use ）. The patient improved and was discharged after 10 days. A total of 12 literatures involving 12 patients were retrieved. Among the 13 patients included in the analysis （including the above clinical case and 12 literature cases ），there were 8 males and 5 females，and 8 patients of them aged 50 and over；the dosage of acarb ose in most patients was within the requirements of the drug instructions. The primary diseases of 12 patients were diabetes mellitus. The latency of skin ADR in 11 patients was within 6 days of administration. Among the 13 patients，the ADR were diagnosed as rash in 4 cases，pustulosis in 3 cases， erythema multiforme in 2 cases， urticaria in 2 cases， maculopapular rash in 1 case and lip swelling in 1 case. The ADR of 1 patient improved after drug withdrawal ，and 12 patients also improved after drug withdrawal and symptomatic treatment such as glucocorticoid or antihistamine. Acarbose was re-used in 2 patients after the improvement of first skin ADR ，and skin ADR occurred again ，and the ADR were improved after drug withdrawal and symptomatic treatment. CONCLUSIONS ：Skin ADR are acarbose-induced rare ADR ，mostly within 6 days of medication ，and are more likely to occur in middle-aged and older men. When the patients suffer from ADR ，the drug should be stopped in time and given glucocorticoids or antihistamines for symptomatic treatment. Clinical pharmacists should do a good job in drug publicity and education ，remind patients to closely monitor relevant indicators and ensure drug safety.
